Raloxifene for postmenopausal osteoporosis

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 1998年 / 40卷 / 1022期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [41] EFFECT OF RALOXIFENE ON OSTEOPOROSIS AND DISEASE ACTIVITY IN POSTMENOPAUSAL FEMALE WITH RHEUMATIC DISEASES
    Lee, W. S.
    Min, I. -S.
    Choi, Y. -J.
    Lee, C. -H.
    Lee, M. -S.
    Yoo, W. -H.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 772 - 772
  • [42] Comparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis
    Reginster, JY
    Adachi, JR
    Qu, Y
    Siddhanti, S
    Keech, C
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S42 - S42
  • [43] Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women
    Ringe, J. D.
    Christodoulakos, G. E.
    Mellstroem, D.
    Petto, H.
    Nickelsen, T.
    Marin, F.
    Pavo, I.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (11) : 2677 - 2687
  • [44] Raloxifene increases intestinal calcium absorption in elderly postmenopausal women with osteoporosis
    Vokrouhlicka, J
    Sysalova, J
    Stepan, JJ
    BONE, 2005, 36 : S439 - S439
  • [45] Raloxifene does not influence fat tissue mass in women with postmenopausal osteoporosis
    Franek, E.
    Bulanowski, M.
    Czerwienska, B.
    Haczynski, J.
    Kokot, F.
    Wiecek, A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S234 - S234
  • [46] Comparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis.
    Adachi, JD
    Reginster, J
    Qu, Y
    Siddhanti, S
    Keech, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S379 - S379
  • [47] Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women
    Lee, Wen-Ling
    Chao, Hsiang-Tai
    Cheng, Ming-Huei
    Wang, Peng-Hui
    MATURITAS, 2008, 60 (02) : 92 - 107
  • [48] Individualizing therapy to prevent postmenopausal osteoporosis: A comparison of hormone therapy, alendronate, and raloxifene
    Col, NF
    Pauker, SG
    Goldberg, RJ
    Eckman, MH
    Orr, RK
    Ross, EM
    Wong, JB
    MEDICAL DECISION MAKING, 1998, 18 (04) : 467 - 467
  • [49] Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years
    Jolly, EE
    Bjarnason, NH
    Neven, P
    Plouffe, L
    Johnston, CC
    Watts, SD
    Arnaud, CD
    Mason, TM
    Crans, G
    Akers, R
    Draper, MW
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (04): : 337 - 344
  • [50] Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis
    Takuo Fujita
    Yoshio Fujii
    Hiromi Munezane
    Mutsumi Ohue
    Yasuyuki Takagi
    Journal of Bone and Mineral Metabolism, 2010, 28 : 477 - 484
12345